Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
There was a bit of toilet trouble on NASA's Artemis 2 mission to the moon - 2Key Training: Picking a Significant for Monetary Achievement
- 3Hidden Island Cameras Capture Rare Tasmanian Species for the First Time Ever
- 4When will the Epstein files be released — and will they reveal anything new?
- 5Figure out How to Consolidate Cutting edge innovations in Senior's SUVs
- Physicists and philosophers have long struggled to understand the nature of time: Here's why
- Top 15 Style Creators Changing the Business
- The most effective method to Connect Successfully with Teachers in a Web based Setting
- IDF: Staying in West Bank refugee camps will quell lone-wolf terror
- 1st human missions to Mars should hunt for signs of life, report says
- U.S. to drop childhood vaccine recommendations as it looks to Denmark, Washington Post reports
- Foreign journalist kidnapped in Iraq: Interior Ministry
- Astronauts' brains change shape and position after time in space, study finds
- What you need to know about Trump accounts as Michael and Susan Dell donate $6 billion to the new early childhood investment program
